Human patients with MGME1 deficiency were reported to have an adult onset, multisystem mitochondrial disorder including progressive external ophthalmoplegia (PEO), muscle wasting, muscle weakness, exercise intolerance, cerebellar atrophy, cerebellar ataxia and cardiomyopathy [9]. Here, MGME1 is linked to progressive external ophthalmoplegia.